Header Logo

Connection

Lawrence Kushi to Heparin, Low-Molecular-Weight

This is a "connection" page, showing publications Lawrence Kushi has written about Heparin, Low-Molecular-Weight.
Connection Strength

0.102
  1. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
    View in: PubMed
    Score: 0.102

© 2025 Kaiser Permanente